BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28554983)

  • 21. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
    Spiecker M; Liao JK
    Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2J2
    Tao P; Jiang Y; Wang H; Gao G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):932-941. PubMed ID: 34707002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice.
    Ma B; Xiong X; Chen C; Li H; Xu X; Li X; Li R; Chen G; Dackor RT; Zeldin DC; Wang DW
    Endocrinology; 2013 Aug; 154(8):2843-56. PubMed ID: 23696562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts.
    Fujii T; Onohara N; Maruyama Y; Tanabe S; Kobayashi H; Fukutomi M; Nagamatsu Y; Nishihara N; Inoue R; Sumimoto H; Shibasaki F; Nagao T; Nishida M; Kurose H
    J Biol Chem; 2005 Jun; 280(24):23041-7. PubMed ID: 15826947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
    Gomes ER; Lara AA; Almeida PW; Guimarães D; Resende RR; Campagnole-Santos MJ; Bader M; Santos RA; Guatimosim S
    Hypertension; 2010 Jan; 55(1):153-60. PubMed ID: 19996065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2J2-produced epoxyeicosatrienoic acids attenuate ischemia/reperfusion-induced acute kidney injury by activating the SIRT1-FoxO3a pathway.
    Zhu Y; Ding A; Yang D; Cui T; Yang H; Zhang H; Wang C
    Life Sci; 2020 Apr; 246():117327. PubMed ID: 31954161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
    Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW
    Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450 Epoxygenase 2J2 Protects Against Lung Ischemia/Reperfusion Injury by Activating the P13K/Akt/GSK-3-β/NF-kB Signaling Pathway During Deep Hypothermic Low Flow in Mice.
    Yang Y; Wang J; Peng W; Shu Y; Mo X
    J Surg Res; 2020 Sep; 253():8-17. PubMed ID: 32305498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice.
    Li R; Xu X; Chen C; Yu X; Edin ML; Degraff LM; Lee CR; Zeldin DC; Wang DW
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):68-78. PubMed ID: 23041291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury.
    Zhao G; Wang J; Xu X; Jing Y; Tu L; Li X; Chen C; Cianflone K; Wang P; Dackor RT; Zeldin DC; Wang DW
    J Lipid Res; 2012 Mar; 53(3):456-466. PubMed ID: 22223859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice.
    Cai Z; Zhao G; Yan J; Liu W; Feng W; Ma B; Yang L; Wang JA; Tu L; Wang DW
    J Lipid Res; 2013 May; 54(5):1448-56. PubMed ID: 23446230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.
    Zuo C; Li X; Huang J; Chen D; Ji K; Yang Y; Xu T; Zhu D; Yan C; Gao P
    Cardiovasc Res; 2018 Apr; 114(5):703-712. PubMed ID: 29415171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis.
    Zhou C; Huang J; Li Q; Zhan C; Xu X; Zhang X; Ai D; Zhu Y; Wen Z; Wang DW
    Free Radic Biol Med; 2018 Mar; 117():168-179. PubMed ID: 29427791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome.
    Zhao G; Wang X; Edwards S; Dai M; Li J; Wu L; Xu R; Han J; Yuan H
    Eur J Pharmacol; 2020 Aug; 881():173276. PubMed ID: 32574674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels.
    Sawada N; Itoh H; Miyashita K; Tsujimoto H; Sone M; Yamahara K; Arany ZP; Hofmann F; Nakao K
    Mol Cell Biol; 2009 Nov; 29(22):6018-32. PubMed ID: 19737918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes.
    Leow JWH; Gu Y; Chan ECY
    Eur J Pharm Sci; 2023 Aug; 187():106475. PubMed ID: 37225005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2.
    Xiao YF; Ke Q; Seubert JM; Bradbury JA; Graves J; Degraff LM; Falck JR; Krausz K; Gelboin HV; Morgan JP; Zeldin DC
    Mol Pharmacol; 2004 Dec; 66(6):1607-16. PubMed ID: 15361551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
    Moshal KS; Zeldin DC; Sithu SD; Sen U; Tyagi N; Kumar M; Hughes WM; Metreveli N; Rosenberger DS; Singh M; Vacek TP; Rodriguez WE; Ayotunde A; Tyagi SC
    J Cell Physiol; 2008 Jun; 215(3):771-81. PubMed ID: 18181170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTY720 Phosphate Activates Sphingosine-1-Phosphate Receptor 2 and Selectively Couples to Gα12/13/Rho/ROCK to Induce Myofibroblast Contraction.
    Sobel K; Monnier L; Menyhart K; Bolinger M; Studer R; Nayler O; Gatfield J
    Mol Pharmacol; 2015 Jun; 87(6):916-27. PubMed ID: 25762025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.